This test is most useful if any of these apply to you.
If you eat a lot of corn, peanuts, rice, dried fruit, or spices, especially from places with hot, humid climates or informal food storage, some of what you swallow can carry a mold-made poison called aflatoxin. This urine test shows whether that poison has moved through your body in the last few days.
Long-term aflatoxin exposure is one of the best-documented dietary causes of liver cancer in humans, and the danger climbs steeply if you also carry hepatitis B or C. A urine result gives you a window into recent exposure that no standard blood panel checks for.
The test looks for AFB1 (aflatoxin B1), a fungal food poison, and its breakdown products in your urine. In practice, much of what shows up is not the original toxin but AFM1 (aflatoxin M1), one of the main products your liver makes after you swallow AFB1. The liver also makes other breakdown products, such as AFQ1, which can appear at even higher levels in some people. Some samples contain the unchanged toxin, but a metabolite like AFM1 is usually the more sensitive signal for the antibody-based tests most often used.
This is an exploratory exposure marker, not a diagnosis. It tells you the toxin recently entered your body, not that you have any disease. Only a small share of the aflatoxin you eat, with human studies reporting roughly 1 to 7%, leaves as urinary AFM1, so the test detects exposure well but is a rough gauge of the exact amount you took in.
This is the single most important thing to understand before you read your result. Urinary aflatoxin reflects the last few days of eating, not your lifetime burden. AFM1 is cleared within roughly 1 to 4 days, and the unchanged toxin appears mainly within the first day.
That short window is why a single urine result can look clean even in someone with steady, long-running exposure. Blood-based aflatoxin markers (aflatoxin-albumin, measured in serum rather than urine) capture exposure over roughly 2 to 3 months and answer a different question about cumulative burden.
The molds that make aflatoxin grow on crops when they are stored warm, damp, or too long. The foods named most often are maize, groundnuts and peanuts, tree nuts, rice, spices, and dried fruit, while milk contributes mainly through AFM1. Handling contaminated grain during milling can also expose people through dust and skin contact, though diet is the dominant route.
Because contamination varies sharply by region, season, and storage, detection rates swing widely. Across surveys, urinary AFM1 has been found in as few as 2% of samples in one rural Chilean group and in as many as 96% of samples in a Bangladeshi mill-worker study. Your own result depends heavily on where your food comes from and how it was stored.
The strongest human evidence links higher urinary aflatoxin to future HCC (hepatocellular carcinoma, the main type of liver cancer). This is the reason the marker matters at all, and the data come from long-running studies that measured the toxin in urine, exactly what this test does.
In a study of 18,244 men in Shanghai, those with any detectable urinary aflatoxin were about 2.4 times as likely to develop liver cancer, rising to about 3.8 times as likely after accounting for hepatitis B, smoking, alcohol, and education. When the specific DNA-damage product (aflatoxin-N7-guanine) was detectable, the reported risk ran several times higher still. In a separate Taiwanese study, people with urinary aflatoxin above the group average had about 76% higher odds of liver cancer, and among those without hepatitis B, the highest quarter of exposure carried roughly 5 times the risk of the lowest quarter.
What this means for you: a detectable or rising result is not a cancer diagnosis, but it flags an exposure pathway worth closing, especially if you have other liver risks. The practical move is to identify and reduce the food source, then confirm the change with a repeat test.
Aflatoxin and chronic viral hepatitis are far more dangerous together than either alone. In the Taiwanese data, carriers of hepatitis B with high urinary aflatoxin had about 15 times the odds of liver cancer, while hepatitis B alone carried roughly 7.5 times the risk. Broader studies using blood-based aflatoxin markers (serum adducts, a related but different measurement) show the same amplifying effect with hepatitis C infection and heavy alcohol use.
This is why your hepatitis B and C status changes how a positive aflatoxin result should be read. If you carry either virus, or drink heavily, a detectable exposure marker deserves more attention than it would in someone with a healthy, uninfected liver.
At extreme exposure levels, aflatoxin causes acute poisoning called aflatoxicosis, with jaundice, vomiting, abdominal pain, and sudden liver failure. A 2004 outbreak in Kenya from heavily contaminated maize caused 317 cases and 125 deaths.
This is a rare, disaster-scale event tied to grossly contaminated staples, not the low-level dietary exposure most urine testing detects. It is included here for completeness, not because a typical positive result implies acute risk.
Beyond the liver, aflatoxin exposure has been linked in human studies to immune suppression (including lower CD4 immune-cell counts in people with HIV), impaired growth in children, and possible effects during pregnancy. These links are less consistent and often rest on blood markers rather than urine, so they should be read as areas of active research, not settled conclusions.
Because urinary aflatoxin turns over in days, a single sample is easy to misread. A few factors matter most:
A low or undetectable result usually means low recent exposure. It does not rule out earlier or ongoing exposure, because this marker simply cannot see back more than a few days.
This marker is highly variable by nature, driven by day-to-day diet and by season. In Bangladeshi cohorts, urinary AFM1 differed by season and between rural and urban areas, so one reading is a snapshot of a moving target.
Repeated sampling is far more informative. Get a baseline, and if you change your food sources or storage habits, retest in a few weeks to a few months to see whether exposure actually fell. If you live with ongoing exposure risk, at least annual checks make sense. Because this is a newer, exploratory measurement without standardized clinical cutoffs, building your own trend line is exactly what gives the number meaning over time.
A detectable or high result is a cue to act on exposure and context, not to panic. Start by reviewing likely food sources and how they are stored, and repeat the test on a fresh sample to confirm it was not a one-off dietary spike.
Then widen the picture with companion testing: your hepatitis B and C status, liver enzymes such as ALT and AST (markers of liver-cell stress), GGT (gamma-glutamyl transferase, another liver enzyme that has run higher in more heavily exposed people), and, in higher-risk situations, AFP (alpha-fetoprotein, a liver-cancer screening blood marker). A serum aflatoxin-albumin test can add the longer-window view that urine cannot.
The combination is what drives decisions. Detectable urine plus hepatitis B or C plus abnormal liver tests is a pattern that warrants a hepatologist and closer surveillance. Isolated low-level detection with normal liver tests and no viral hepatitis usually calls for reducing the food source and rechecking, rather than an urgent workup.
Evidence-backed interventions that affect your AFB1 level
Aflatoxin B1 is best interpreted alongside these tests.
Aflatoxin B1 is included in these pre-built panels.